Kusajili – Centralise les essais cliniques mondiaux

Votre recherche

Source: nct - Pays: Bulgaria,Estonia,Hungary,Spain,Russian Federation,Czech Republic,Lithuania,Poland,United States,India - Phase: complete

nct MAJ Il y a 5 ans

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia The purpose of this study is to demonstrate the effectiveness of paliperidone palmitate in patients with Schizophrenia.

Pays Austria, Bulgaria, Czech Republic, Estonia, France, Germany, Hungary, India, Lithuania, Poland, Russian Federation, Spain, Ukraine, United States,
Organes Aucun
Spécialités Aucun

Essai clos aux inclusions

Plus d'informations

1